Epidemiology & Genomics Research Program
Supporting research in human populations to understand determinants of cancer occurrence and outcomes and translating findings to clinical and public health interventions.
Funding Opportunities
Assay Validation of High Quality Markers for Clinical Studies in Cancer
PAR-20-313 (UH2/UH3, Clinical Trial Not Allowed) and PAR-20-314 (UH3, Clinical Trials Not Allowed)
Expires October 11, 2023
Co-infection and Cancer
PAR-20-061 (R21 Clinical Trial Not Allowed) and PAR-20-062 (R01 Clinical Trial Not Allowed)
Expires January 8, 2023
Core Infrastructure Support for Cancer Epidemiology Cohorts
PAR-20-294 (U01 - Clinical Trial Not Allowed)
Expires November 10, 2022
Notice of Special Interest: Research in the Emergency Setting
NOT-NS-20-005
Expires September 8, 2022
Genomic Expert Curation Panels
PAR-20-101 (U24 - Clinical Trial Not Allowed)
Expires May 27, 2022
Diet and Physical Activity Assessment Methodology
PA-18-856 (R01 - Clinical Trial Not Allowed) and PAR-18-857 (R21 - Clinical Trial Not Allowed)
Expires September 8, 2021
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors
RFA-CA-20-027 (R01 - Clinical Trial Optional) and RFA-CA-20-028 (R21 - Clinical Trial Optional)
Expires July 31, 2021
Utilizing In Vitro Functional Genomics Advances for Gene-Environment (GxE) Discovery and Validation
RFA-ES-20-018 (R01, Clinical Trial Not Allowed)
Expires February 2, 2021
New Cohorts for Environmental Exposures and Cancer Risk & Coordinating Center
RFA-CA-20-049 (UG3/UH3 - Clinical Trial Not Allowed) and RFA-CA-20-050 (U24 - Clinical Trial Not Allowed)
Expires January 30, 2021
Featured Resource
New Webinar Series Focuses on Body Composition and Cancer Outcomes Research
The purpose of the Body Composition and Cancer Outcomes Research webinar series is to provide an opportunity for researchers and other interested individuals to share lessons learned, new methodologies, and new research integrating measures of body composition in cancer epidemiology research.
Meet Our Associate Director
An Interview with Kathy J. Helzlsouer, M.D., M.H.S.
Dr. Helzlsouer speaks about her background in oncology and epidemiology, the people and experiences that drive her passion for cancer research, and her ideas about future directions for EGRP.
What's New
Connect With Us
Subscribe for Updates
Subscribe
You can subscribe and unsubscribe at any time by entering your email address and selecting your preferences on the page that follows.
Follow Us on Twitter
Need Help?
EGRP staff can answer questions on grant funding, policies, and research resources. If you do not know who to contact we will do our best to connect you with someone who can help you.
Email Us(240) 276-6730